Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$198,090,923
New position
Shares Held
1,004,416
first reported quarter
Ownership
0.065%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.38302456352747.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6169754364725373.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JONES FINANCIAL COMPANIES LLLP holds $2,302,649,106 across 19 Drug Manufacturers - General names. AZN ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
650,867 | $598,647,939 | |
| 2 | JNJ |
Johnson & Johnson
|
1,551,388 | $379,221,282 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,659,381 | $319,896,940 | |
| 4 | NVS |
Novartis AG
|
1,821,796 | $278,279,339 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
1,004,416 | $198,090,923 | |
| 6 | ABBV |
AbbVie Inc.
|
777,405 | $169,077,812 | |
| 7 | PFE |
Pfizer Inc
|
4,521,343 | $126,959,311 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
483,233 | $67,348,183 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $198,090,923 | 1,004,416 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||